Pages that link to "Q39951118"

The following pages link to envM genes of Salmonella typhimurium and Escherichia coli (Q39951118):

Displaying 45 items.

• Role of fatty acid de novo biosynthesis in polyhydroxyalkanoic acid (PHA) and rhamnolipid synthesis by pseudomonads: establishment of the transacylase (PhaG)-mediated pathway for PHA biosynthesis in Escherichia coli (Q24549917) (← links)
• Diazaborine treatment of yeast cells inhibits maturation of the 60S ribosomal subunit (Q24563995) (← links)
• Molecular basis of triclosan activity (Q27617904) (← links)
• Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition (Q27619988) (← links)
• Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor (Q27671875) (← links)
• Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl acyl carrier protein reductase (Q27732215) (← links)
• Diazaborine resistance in the yeast Saccharomyces cerevisiae reveals a link between YAP1 and the pleiotropic drug resistance genes PDR1 and PDR3. (Q27938341) (← links)
• Mechanism of triclosan inhibition of bacterial fatty acid synthesis (Q28140952) (← links)
• Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus (Q28485592) (← links)
• Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei (Q28492113) (← links)
• Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis (Q28492770) (← links)
• Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase (Q28492833) (← links)
• Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum (Q30049704) (← links)
• Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. (Q32145030) (← links)
• In Vivo Evidence that S -Adenosylmethionine and Fatty Acid Synthesis Intermediates Are the Substrates for the LuxI Family of Autoinducer Synthases (Q33730808) (← links)
• Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery (Q33947768) (← links)
• Lipid biosynthesis as a target for antibacterial agents (Q34395560) (← links)
• Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii (Q35016560) (← links)
• Genetic strategies for antibacterial drug discovery (Q35140832) (← links)
• Agents that increase the permeability of the outer membrane. (Q35403079) (← links)
• Fatty acid biosynthesis as a target for novel antibacterials (Q35713880) (← links)
• The reductase steps of the type II fatty acid synthase as antimicrobial targets (Q36052456) (← links)
• Anabaena sp. strain PCC 7120 bifA gene encoding a sequence-specific DNA-binding protein cloned by in vivo transcriptional interference selection (Q36102347) (← links)
• Genetic map of Salmonella typhimurium, edition VIII (Q36669927) (← links)
• Functions of the gene products of Escherichia coli. (Q37059813) (← links)
• The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance (Q37218845) (← links)
• Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages (Q37302019) (← links)
• Bacterial fatty acid synthesis and its relationships with polyketide synthetic pathways (Q37442104) (← links)
• Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic (Q37545596) (← links)
• Triclosan - an update (Q37821965) (← links)
• An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds (Q38505082) (← links)
• Antiplasmodial drug targets: a patent review (2000 - 2013). (Q38632903) (← links)
• Antimicrobial agent resistance in mycobacteria: molecular genetic insights. (Q39820619) (← links)
• Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge (Q40345423) (← links)
• Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant (Q44234410) (← links)
• Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases (Q44279030) (← links)
• Synthesis, characterization, and antibacterial activity of structurally complex 2-acylated 2,3,1-benzodiazaborines and related compounds (Q46098028) (← links)
• The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes (Q48080193) (← links)
• Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus. (Q54443492) (← links)
• Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli (Q71823957) (← links)
• Deficiency in fatty acid synthase leads to premature cell death and dramatic alterations in plant morphology (Q73544255) (← links)
• Diazaborine treatment of Baker's yeast results in stabilization of aberrant mRNAs (Q74285043) (← links)
• Sequences surrounding the transcription initiation site of the Arabidopsis enoyl-acyl carrier protein reductase gene control seed expression in transgenic tobacco (Q77918536) (← links)
• Adaptive Evolution of Geobacter sulfurreducens in Coculture with Pseudomonas aeruginosa (Q91707700) (← links)
• New nucleotide sequence data on the EMBL File Server (Q93511420) (← links)